Literature DB >> 11605806

Duration of enterovirus shedding in stool.

P W Chung1, Y C Huang, L Y Chang, T Y Lin, H C Ning.   

Abstract

Excretion of enterovirus (EV) may persist for months after an EV infection; the exact duration of excretion, however, is not yet known. Twelve children who were infected with EV between September 1998 and June 1999 were enrolled into this study. The patients included 4 boys and 8 girls, aged from 1 month to 5 years. Six patients were asked to join this virus isolation program, and the other 6 were followed-up regularly. Only 2 of the patients were infected with EV 71. To delineate the duration of EV shedding in each case, throat swabs for virus isolation were performed every 1 or 2 weeks for at least 1 month, and stools were analyzed for at least 2 months following the same schedule. After the infection, EV was identifiable in the throat in 4 patients for 1 to 2 weeks. Excretion of EV through stool was evidenced for up to 7 weeks in 6 patients, 8 weeks in 3, and 11 weeks in 1. In the 2 patients who failed to show up for follow-up visits from the 7th week, excretion of EV through stool was recorded for at least 7 weeks. Different serotypes of EV could be isolated from the same patient who was not experiencing febrile illness in 2 instances in a series of virus cultures. Coexistence of vaccine poliovirus and non-polio EV, both isolated from stool, was evidenced in 2 patients. Results from this study suggest that EV may not be identified from the throat 2 weeks after the infection, but its excretion through stool can persist for up to 11 weeks. This study also demonstrated that subclinical EV coinfection could occur, and that live vaccine poliovirus did not interfere with the invasion of other non-polio EV.

Entities:  

Mesh:

Year:  2001        PMID: 11605806

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  36 in total

Review 1.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

Review 2.  How to understand the efficacy measurements for enterovirus type 71 vaccine?

Authors:  Jing-Xin Li; Fan-Yue Meng; Zheng-Lun Liang; Qun-Ying Mao; Feng-Cai Zhu
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

Review 3.  Acute Flaccid Paralysis and Enteroviral Infections.

Authors:  Ari Bitnun; E Ann Yeh
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

Review 4.  [Atypical variant of hand-foot-mouth disease].

Authors:  Thomas Kuntz; Bijan Koushk-Jalali; Christian Tigges; Steffi Silling; Veronica di Cristanziano; Ulrike Wieland; Frank Oellig; Alexander Kreuter
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

5.  Residual viral and bacterial contamination of surfaces after cleaning and disinfection.

Authors:  Era Tuladhar; Wilma C Hazeleger; Marion Koopmans; Marcel H Zwietering; Rijkelt R Beumer; Erwin Duizer
Journal:  Appl Environ Microbiol       Date:  2012-08-31       Impact factor: 4.792

6.  Optimization of a Class of Tryptophan Dendrimers That Inhibit HIV Replication Leads to a Selective, Specific, and Low-Nanomolar Inhibitor of Clinical Isolates of Enterovirus A71.

Authors:  Eva Rivero-Buceta; Liang Sun; Belén Martínez-Gualda; Elisa G Doyagüez; Kim Donckers; Ernesto Quesada; María-José Camarasa; Leen Delang; Ana San-Félix; Johan Neyts; Pieter Leyssen
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 7.  The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy.

Authors:  Annick A J M van de Ven; David P Hoytema van Konijnenburg; Annemarie M J Wensing; Joris M van Montfrans
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

8.  Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery.

Authors:  Jun Han; Xue-Jun Ma; Jun-Feng Wan; Ying-Hui Liu; Yan-Ling Han; Cao Chen; Chan Tian; Chen Gao; Miao Wang; Xiao-Ping Dong
Journal:  BMC Infect Dis       Date:  2010-06-18       Impact factor: 3.090

9.  Enterovirus 71-associated hand, foot and mouth diseases with neurologic symptoms, a university hospital experience in Korea, 2009.

Authors:  Hye Kyung Cho; Na Yong Lee; Hyunju Lee; Hae Soon Kim; Jeong Wan Seo; Young Mi Hong; Seung Joo Lee; Sun Wha Lee; Doo Sung Cheon; Ji Young Hong; Byung Hak Kang; Jong-Hyun Kim; Kyung-Hyo Kim
Journal:  Korean J Pediatr       Date:  2010-05-31

10.  Enterovirus 71 infection: An experience in Korea, 2009.

Authors:  Kyung Hyo Kim
Journal:  Korean J Pediatr       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.